Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines

Drug Metabolism and Disposition

Volumn 35, Issue 8, 2007, Pages 1333-1340

  Hilgendorf, Constanze ^a   Ahlin, Gustav ^b   Seithel, Annick ^a   Artursson, Per ^b   Ungell, Anna Lena ^a   Karlsson, Johan ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; HUMAN PEPTIDE TRANSPORTER 1; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 5; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 3; PEPTIDE TRANSPORTER 1; TRANSCRIPTION FACTOR OCTN2; TRANSPORT PROTEIN BSEP; TRANSPORT PROTEIN NTCP; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ADULT; AGED; ANIMAL CELL; ARTICLE; COLON; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TRANSPORT; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE; JEJUNUM; KIDNEY; LIVER; LIVER LEVEL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPECIES COMPARISON; SPECIES DIFFERENCE; TISSUE CULTURE CELL;

AGED; AGED, 80 AND OVER; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CACO-2 CELLS; CELL LINE, TUMOR; COLON; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTESTINES; JEJUNUM; KIDNEY; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS;

EID: 34547169521     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.014902     Document Type: Article

References (41)

1. Anderle P, Rakhmanova V, Woodford K, Zerangue N, and Sadee W (2003) Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines. Pharmacol Res 20:3-15.
2. Applied Biosystems (1997) Relative Quantification of Gene Expression User Bulletin #2: ABI PRISM 7700 Sequence Detection System.
3. Augustine LM, Markelewicz RJ, Jr., Boekelheide K, and Cherrington NJ (2005) Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metab Dispos 33:182-189.
4. Bakos E and Homolya L (2007) Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch 453:621-641.
5. Behrens I, Kamm W, Dantzig AH, and Kissel T (2004) Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. J Pharm Sci 93:1743-1754.
6. Bleasby K, Castle JC, Roberts CJ, Cheng C, Bailey WJ, Sina JF, Kulkarni AV, Hafey MJ, Evers R, Johnson JM, et al. (2006) Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36:963-988.
7. Cui Y, Konig J, and Keppler D (2001) Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 60:934-943.
8. Cundy KC, Annamalai T, Bu L, De Vera J, Estrela J, Luo W, Shirsat P, Torneros A, Yao F, Zou J, et al. (2004) XP13512 [({+/-})-1-([({alpha}- Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug. II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J Pharmacol Exp Ther 311:324-333.
9. de Lange EC (2004) Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56:1809.
10. Dietrich CG, Geier A, and Oude Elferink RPJ (2003) ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52:1788-1795.
11. Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M, Kanai Y, Sophasan S, and Endou H (2004) Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 94:297-304.
12. Englund G, Rorsman F, Rönnblom A, Karlbom U, Lazorova L, Gråsjö J, Kindmark A, and Artursson P (2006) Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 29:269-277.
13. Halestrap AP and Meredith D (2004) The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447:619-628.
14. Ito K, Suzuki H, Horie T, and Sugiyama Y (2005) Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharmacol Res 22:1559-1577.
15. Jedlitschky G, Hoffmann U, and Kroemer HK (2006) Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert OpinDrug Metab Toxicol 2:351-366.
16. Jonker JW and Schinkel AH (2004) Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308:2-9.
17. Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, and Kullak-Ublick GA (2001) Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J Biol Chem 276:37206-37214.
18. Koepsell H and Endou H (2004) The SLC22 drug transporter family. Pflugers Arch 447:666-676.
19. Landowski CP, Sun D, Foster DR, Menon SS, Barnett JL, Welage LS, Ramachandran C, and Amidon GL (2003) Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters. J Pharmacol Exp Ther 306:778-786.
20. Liu L, Cui Y, Chung AY, Shitara Y, Sugiyama Y, Keppler D, and Pang KS (2006) Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers. J Pharmacol Exp Ther 318:395-402.
21. Mikkaichi T, Suzuki T, Tanemoto M, Ito S, and Abe T (2004) The organic anion transporter (OATP) family. Drug Metab Pharmacokinet 19:171-179.
22. Nagasawa K, Nagai K, Sumitani Y, Moriya Y, Muraki Y, Takara K, Ohnishi N, Yokoyama T, and Fujimoto S (2002) Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells. J Pharm Sci 91:2605-2613.
23. Ninomiya M, Ito K, and Horie T (2005) Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2. Drug Metab Dispos 33:225-232.
24. Nishimura M and Naito S (2005) Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamily. Drug Metab Pharmacokinet 20:452-477.
25. Okamura A, Emoto A, Koyabu N, Ohtani H, and Sawada Y (2002) Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1. Br J Pharmacol 137:391-399.
26. Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, and Moriyama Y (2005) A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A 102:17923-17928.
27. Pfaffl M, Tichopad A, Prgomet C, and Neuvians T (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations. Biotechnol Lett 26:509-515.
28. Pfrunder A, Gutmann H, Beglinger C, and Drewe J (2003) Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol, 55:59-66.
29. Seithel A, Karlsson J, Hilgendorf C, Bjorquist A, and Ungell A-L (2006) Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur J Pharm Sci 28:291-299.
30. Shitara Y, Sato H, and Sugiyama Y (2005) Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 45:689-723.
31. Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD, and Amidon GL (2002) Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharmacol Res 19:1400-1416.
32. Sun J, He ZG, Cheng G, Wang SJ, Hao XH and Zou MJ (2004) Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit 10:RA5-RA14.
33. Sun W, Wu RR, van Poelje PD, and Erion MD (2001) Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 283:417-422.
34. Taipalensuu J, Tavelin S, Lazorova L, Svensson A-C and Artursson P (2004) Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activity. Eur J Pharm Sci 21:69-75.
35. Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, and Artursson P (2001) Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299:164-170.
36. Trauner M and Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633-671.
37. Treiber A, Schneiter R, Delahaye S, and Clozel M (2004) Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat. J Pharmacol Exp Ther 308:1121-1129.
38. Vandesompele J, DePreter K, Pattyn F, Poppe B, VanRoy N, DePaepe A, and Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:1-12.
39. Wang D-S, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, and Sugiyama Y (2002) Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 302:510-515.
40. Zimmermann C, Gutmann H, Hruz P, Gutzwiller JP, Beglinger C, and Drewe J (2005) Mapping of multidrug resistance gene 1 and multidrug resistance- associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab Dispos 33:219-224.
41. Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, Fuchsbichler A, Halilbasic E, Denk H, Marschall H-U and Trauner M (2005) Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter alpha/beta in the adaptive response to bile acids. Am J Physiol G923-G932.